MedPath

A community-based trial to reduce malaria by improving homes and treating cattle in southwest Ethiopia.

Phase 3
Not yet recruiting
Conditions
Malaria
Registration Number
PACTR202306667462566
Lead Sponsor
The Norwegian Programme for Capacity Development in Higher Education and Research for Development.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
9000
Inclusion Criteria

All households and members in the clusters assigned to either of the interventions or control and willing to sign informed consent to participate in the malaria study for two years will be included.
Villages close to the shores of the two Rift Valley lakes and endemic for malaria will be included in the study to minimize the variation between villages.
The flight distance of mosquitoes will be considered in selecting clusters for the study to reduce the diversion effect of the intervention and contamination due to mosquito movement.

All cattle except lactating cows and those planned to be used for meat in the near future will be involved in the study.

Exclusion Criteria

Those households that refuse to participate in the study or whose house structures are unsuitable for screening will be excluded.
Children below one year will not been enrolled in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.